Clinical Scorecard: Insights from an Expert Panel on the Management of GERD Following Esophageal POEM: Findings from a National Survey
At a Glance
Category
Detail
Condition
Gastroesophageal reflux disease (GERD) following esophageal per-oral endoscopic myotomy (E-POEM) for achalasia
Key Mechanisms
Degeneration of esophageal myenteric plexus ganglion cells causing impaired esophageal contraction and LES relaxation; E-POEM disrupts LES leading to increased GERD risk
Target Population
Patients undergoing E-POEM for achalasia
Care Setting
Specialized gastroenterology and advanced endoscopy clinical settings
Key Highlights
GERD occurs in approximately 38% of patients after E-POEM, often with poor symptom correlation to esophagitis severity.
No reliable patient or procedural predictors exist for post-POEM GERD development, including achalasia subtype or E-POEM technique.
Long-term risks of GERD post-POEM, including esophageal adenocarcinoma, remain theoretical due to limited follow-up data.
Guideline-Based Recommendations
Diagnosis
Consider pH testing for definitive GERD evaluation post-POEM, recognizing confounding by esophageal stasis.
Additional workup recommended for patients with refractory or atypical reflux symptoms on maximal PPI therapy.
Management
Strong consideration for acid suppression therapy (e.g., proton pump inhibitors) at discharge after E-POEM.
No consensus on duration or de-escalation of acid suppression therapy.
Monitoring & Follow-up
All patients should undergo monitoring for GERD following E-POEM.
Long-term post-procedure surveillance is encouraged due to potential GERD complications, though no specific surveillance method or timeline is established.
Risks
Achalasia patients have a fivefold increased risk of esophageal squamous cell carcinoma and adenocarcinoma compared to non-achalasia patients.
Post-POEM GERD-driven esophageal adenocarcinoma risk remains theoretical and unquantified.
Patient & Prescribing Data
Patients treated with E-POEM for achalasia
Most patients respond to acid suppression therapy; however, no predictors reliably identify those who will develop post-POEM GERD.
Clinical Best Practices
Implement acid suppression therapy at discharge for patients undergoing E-POEM.
Perform clinical follow-up including reflux assessment post-POEM.
Use pH testing selectively in patients with persistent or atypical reflux symptoms despite maximal acid suppression.
Encourage long-term surveillance for GERD complications, tailored to individual patient risk and clinical presentation.
